Delivery Order SPE2DB22D3004-SPE2DB24FQP14

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used for the treatment of diabetes. The contract has a firm fixed price and an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $36,271.26 firm fixed-price delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a performance period ending on May 21, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. The contract does not have a set-aside designation, indicating open competition. It is a delivery order contract with a firm fixed price pricing type, with a final completion date of July 9,...
The U.S. Defense Logistics Agency (DLA) awarded a $6,095.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is for the provision of Trulicity 3 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $2,757.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a diabetes medication. This is a delivery order contract with a firm fixed price, and the ultimate completion date is July 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $2,740.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. This is a firm fixed-price delivery order contract with an ultimate completion date of August 16, 2024. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award of $3,152.34 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price and a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,741.68 delivery order is for the supply of Trulicity 3 mg/0.5 ml pen, a medication used to treat type 2 diabetes. The contract has a firm fixed price and is set to expire on August 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,593.02 firm fixed-price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,015.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. This is a delivery order contract with a firm fixed price pricing type, with a completion date of July 19, 2024. The contract was not set aside for any specific business categories....
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQP14
    Delivery Order

This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of June 4, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was made on a full and open competition basis without a set-aside designation.

Generated 9/2/24, 3:47 PM